Jove
Visualize
Contact Us

Related Experiment Videos

Update on osteoporosis therapy.

João Lindolfo C Borges1, John P Bilezikian

  • 1Universidade Catolica de Brasilia, DF, Brazil. jlborges@metabolismo.com.br

Arquivos Brasileiros De Endocrinologia E Metabologia
|November 23, 2006
PubMed
Summary

Osteoporosis treatment, including medications and lifestyle changes, significantly reduces fracture risk in postmenopausal women. However, adherence to pharmacologic therapy for osteoporosis often falls below one year.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bacterial specificity of the gut microbiome predicts bone density in primary hyperparathyroidism.

Bone research·2026
Same author

Clinical profile, treatment practices, and complications in chronic hypoparathyroidism in a Middle Eastern cohort.

Journal of the Endocrine Society·2026
Same author

Journal of Bone and Mineral Research (JBMR) 40th anniversary celebration the third decade (part 1).

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026
Same author

Vitamin D in Gut and Systemic Immune Tolerance and in Infections' Risk: An International Evidence-Based Consensus Statement.

Reviews in endocrine & metabolic disorders·2026
Same author

Treatment of hypoparathyroidism (HypoPT): Position Statement of the Expert Group for Polish Society of Endocrinology - update 2026.

Endokrynologia Polska·2026
Same author

Journal of Bone and Mineral Research (JBMR) 40th anniversary celebration: the beginning and first decade.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Bone health and skeletal disorders
  • Endocrinology and metabolic diseases
  • Geriatric medicine

Background:

  • Osteoporosis is a major skeletal disorder defined by diminished bone strength, elevating fracture risk.
  • Fractures associated with osteoporosis lead to severe morbidity, mortality, functional decline, and psychological distress.
  • Pharmacologic interventions offer significant fracture risk reduction in postmenopausal women beyond calcium and vitamin D.

Purpose of the Study:

  • To summarize the current understanding of osteoporosis management.
  • To highlight the benefits of pharmacotherapeutic interventions for postmenopausal osteoporosis.
  • To emphasize the importance of a comprehensive approach to osteoporosis treatment.

Main Methods:

  • Review of pharmacologic agents for osteoporosis, including bisphosphonates, SERMs, calcitonin, and teriparatide.
  • Emphasis on the role of nutritional support, exercise, and avoidance of smoking and excessive alcohol.
  • Discussion of treatment adherence challenges.

Main Results:

  • Pharmacotherapeutic interventions significantly reduce fracture risk in postmenopausal women.
  • Combined approach including nutrition, exercise, and lifestyle modification is crucial.
  • Most patients discontinue osteoporosis pharmacologic therapy within one year.

Conclusions:

  • Pharmacologic therapy, alongside lifestyle factors, is effective in reducing osteoporosis-related fractures.
  • Improving long-term adherence to osteoporosis treatment is a critical unmet need.
  • Comprehensive patient management strategies are essential for effective osteoporosis care.

Related Experiment Videos